v3.26.3
Revenue Recognition - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Nov. 30, 2023
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Disaggregation of Revenue [Line Items]            
Revenue from contract with customers excluding assessed tax   $ 411,537 $ 334,206 $ 1,142,139 $ 904,578  
Contract with customer liability amount of revenue recognized that was included in the opening balance       64,800 67,000  
Location, Statement of Financial Position, Balance [Axis]: us-gaap:AccountsReceivableNetCurrent            
Disaggregation of Revenue [Line Items]            
Contract with customer receivable after allowance for credit loss current   40,500   40,500   $ 8,100
Long-Term Contract with Customer [Member]            
Disaggregation of Revenue [Line Items]            
Revenue, remaining performance obligation   514,000   514,000    
Commercialization and Reference Laboratory Agreement Member With Personalis Inc [Member]            
Disaggregation of Revenue [Line Items]            
Term of agreement 3 years          
Personalis [Member] | Commercialization and Reference Laboratory Agreement Member With Personalis Inc [Member]            
Disaggregation of Revenue [Line Items]            
Aggregate milestone amount payable $ 12,000          
Contract with customer assets net current   $ 1,500   $ 1,500   $ 4,700
One Year [Member] | Long-Term Contract with Customer [Member]            
Disaggregation of Revenue [Line Items]            
Revenue, remaining performance obligation, percentage   44.00%   44.00%    
Two Year [Member] | Long-Term Contract with Customer [Member]            
Disaggregation of Revenue [Line Items]            
Revenue, remaining performance obligation, percentage   29.00%   29.00%    
Three Year [Member] | Long-Term Contract with Customer [Member]            
Disaggregation of Revenue [Line Items]            
Revenue, remaining performance obligation, percentage   14.00%   14.00%    
Four and Thereafter [Member] | Long-Term Contract with Customer [Member]            
Disaggregation of Revenue [Line Items]            
Revenue, remaining performance obligation, percentage   13.00%   13.00%    
Genomics Product [Member] | Self-Pay [Member]            
Disaggregation of Revenue [Line Items]            
Revenue from contract with customers excluding assessed tax   $ 31,000 17,500 $ 77,700 49,900  
Clinical Order [Member] | Third-Party Payor [Member]            
Disaggregation of Revenue [Line Items]            
Revenue from contract with customers excluding assessed tax   272,500 235,400 776,200 638,600  
Insights Product [Member]            
Disaggregation of Revenue [Line Items]            
Revenue from contract with customers excluding assessed tax   88,900 69,000 237,900 175,700  
Trials Product [Member]            
Disaggregation of Revenue [Line Items]            
Revenue from contract with customers excluding assessed tax   9,600 9,200 28,500 28,700  
Next Product [Member]            
Disaggregation of Revenue [Line Items]            
Revenue from contract with customers excluding assessed tax   $ 9,600 $ 3,200 $ 21,600 $ 11,600